2013 Patients Pharmacology 
Medgadget
MAY 2, 2023
The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution.
European Pharmaceutical Review
JANUARY 31, 2025
More importantly, patient outcomes have also been transformative, with more patients getting faster access to biological therapy. Instead they treat a minority population of patients, either specific indications or by targeting a subset of patients. She holds a MSc in Pharmacology. 6 billion in 2024 alone).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 27, 2023
Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. As this is an autologous therapy, there is a lot of patient-to-patient variability. 1 Furthermore, there are 63.3
European Pharmaceutical Review
OCTOBER 19, 2022
10 There is a fear that such practices discourage innovative approaches, impacting on patient welfare. Patent Protection of Pharmacologically Active Metabolites: Theoretical and Technological Analysis on the Jurisprudence of Four Regions. 23 April 2013. Cited 25 September 2022]. Li-dar Wang R, Huang P-C. 29(3), article 2.
Pharmaceutical Technology
OCTOBER 10, 2022
The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). Moreover, any potential use of Lybrido or Lybridos would also come with a screening test that will determine which of these drugs will benefit the patient, says Simon.
Expert insights. Personalized for you.
86 
Let's personalize your content